CAMK2N1 and ovarian carcinoma: Recently, Peng et al. found that DNA hypermethylation contributes to the downregulation of CAMK2N1 in hepatocellular carcinoma, cervical, and ovarian cancer, which serves as a potential prognostic biomarker [24, 27, 29, 30].